Timber Pharmaceuticals Inc. (TMBR) is on the roll with an average volume of 987.11K in the recent 3 months

Let’s start up with the current stock price of Timber Pharmaceuticals Inc. (TMBR), which is $1.96 to be very precise. The Stock rose vividly during the last session to $1.89 after opening rate of $1.82 while the lowest price it went was recorded $1.75 before closing at $1.86.

Recently in News on July 22, 2020, Timber Pharmaceuticals Announces European Patent Office Intends to Grant Patent for BPX-01 and BPX-04. Stable topical composition has potential to reduce side effects of orally delivered compositions in treatment of acne and rosacea . You can read further details here

Timber Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.6000 on 01/27/20, with the lowest value was $1.7500 for the same time period, recorded on 07/30/20.

Timber Pharmaceuticals Inc. (TMBR) full year performance was -63.15%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Timber Pharmaceuticals Inc. shares are logging -84.44% during the 52-week period from high price, and 12.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.75 and $12.60.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2608543 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Timber Pharmaceuticals Inc. (TMBR) recorded performance in the market was -63.44%, having the revenues showcasing -52.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 22.79M, as it employees total of 3 workers.

Analysts verdict on Timber Pharmaceuticals Inc. (TMBR)

During the last month, 0 analysts gave the Timber Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.1964, with a change in the price was noted -2.4406. In a similar fashion, Timber Pharmaceuticals Inc. posted a movement of -55.52% for the period of last 100 days, recording 668,185 in trading volumes.

Timber Pharmaceuticals Inc. (TMBR): Technical Analysis

Raw Stochastic average of Timber Pharmaceuticals Inc. in the period of last 50 days is set at 10.85%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 28.08%. In the last 20 days, the company’s Stochastic %K was 15.43% and its Stochastic %D was recorded 9.73%.

Let’s take a glance in the erstwhile performances of Timber Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -63.44%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -67.42%, alongside a downfall of -63.15% for the period of the last 12 months. The shares increased approximately by -11.85% in the 7-day charts and went up by -14.68% in the period of the last 30 days. Common stock shares were lifted by -52.70% during last recorded quarter.